Sami Hamdoun

693 total citations
17 papers, 413 citations indexed

About

Sami Hamdoun is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Sami Hamdoun has authored 17 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Infectious Diseases. Recurrent topics in Sami Hamdoun's work include Synthesis and biological activity (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Sami Hamdoun is often cited by papers focused on Synthesis and biological activity (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Sami Hamdoun collaborates with scholars based in Germany, Sudan and Macao. Sami Hamdoun's co-authors include Thomas Efferth, Vincent Kam Wai Wong, Philipp Jung, Chenglai Xia, Betty Yuen Kwan Law, Sookja Kim Chung, Li Yang, Xiaoling Guo, Edmond Fleischer and Liang Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Sami Hamdoun

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sami Hamdoun Germany 10 207 63 61 58 57 17 413
Md. Junaid Bangladesh 14 219 1.1× 96 1.5× 59 1.0× 77 1.3× 44 0.8× 30 484
Rackhyun Park South Korea 12 230 1.1× 70 1.1× 71 1.2× 44 0.8× 38 0.7× 28 639
S. M. Zahid Hosen Bangladesh 15 283 1.4× 103 1.6× 65 1.1× 45 0.8× 51 0.9× 47 564
Yu‐Shih Lin Taiwan 10 204 1.0× 107 1.7× 136 2.2× 108 1.9× 42 0.7× 21 576
Aml Ghanem Egypt 10 213 1.0× 85 1.3× 30 0.5× 30 0.5× 57 1.0× 15 435
Minsu Jang South Korea 11 180 0.9× 70 1.1× 68 1.1× 43 0.7× 20 0.4× 19 517
Sara Abdelfatah Germany 17 367 1.8× 62 1.0× 29 0.5× 65 1.1× 109 1.9× 32 621
Priya Wazir India 14 161 0.8× 38 0.6× 58 1.0× 36 0.6× 64 1.1× 31 385
Xun Luo China 6 167 0.8× 84 1.3× 40 0.7× 31 0.5× 33 0.6× 8 494
T. Ngoc Han Pham Vietnam 5 191 0.9× 164 2.6× 37 0.6× 29 0.5× 27 0.5× 8 404

Countries citing papers authored by Sami Hamdoun

Since Specialization
Citations

This map shows the geographic impact of Sami Hamdoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sami Hamdoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sami Hamdoun more than expected).

Fields of papers citing papers by Sami Hamdoun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sami Hamdoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sami Hamdoun. The network helps show where Sami Hamdoun may publish in the future.

Co-authorship network of co-authors of Sami Hamdoun

This figure shows the co-authorship network connecting the top 25 collaborators of Sami Hamdoun. A scholar is included among the top collaborators of Sami Hamdoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sami Hamdoun. Sami Hamdoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hamdoun, Sami, et al.. (2024). Insilco vaccine design of spike and hemagglutinin esterase proteins of bovine coronavirus. SHILAP Revista de lepidopterología. 9(1). 2 indexed citations
2.
Hamdoun, Sami, et al.. (2024). Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets. Istanbul Journal of Pharmacy. 54(3). 446–455.
3.
Hamdoun, Sami, Ruihong Chen, Yuan Qing Qu, et al.. (2021). Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacological Research. 172. 105820–105820. 69 indexed citations
4.
Yang, Li, Sami Hamdoun, Sookja Kim Chung, et al.. (2021). 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection. Frontiers in Pharmacology. 12. 634176–634176. 40 indexed citations
5.
Yang, Li, Sami Hamdoun, Paolo Coghi, et al.. (2021). Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding. Phytomedicine. 87. 153591–153591. 53 indexed citations
6.
Xu, Su, Betty Yuen Kwan Law, Sami Hamdoun, et al.. (2020). SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells. Pharmacological Research. 153. 104660–104660. 42 indexed citations
7.
Gioti, Katerina, Sami Hamdoun, Thomas Efferth, et al.. (2020). Synthesis of novel xanthone and acridone carboxamides with potent antiproliferative activities. Arabian Journal of Chemistry. 13(11). 7953–7969. 3 indexed citations
8.
Abdelfatah, Sara, Angela Berg, Qi Huang, et al.. (2019). MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate. Acta Pharmaceutica Sinica B. 9(5). 1021–1034. 30 indexed citations
9.
Dawood, Mona, Sami Hamdoun, & Thomas Efferth. (2018). Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology. Frontiers in Pharmacology. 9. 143–143. 17 indexed citations
10.
Mohamed, Magdi Awadalla, Amina Ibrahim Dirar, Mohamed Elbadawi, et al.. (2017). In silico assessment of the druggability of two novel germacranolides isolated from Capparis decidua (Forsk.) as carbonic anhydrase II inhibitors. Journal of Applied Pharmaceutical Science. 93–97. 1 indexed citations
11.
Hamdoun, Sami, Edmond Fleischer, Anette Klinger, & Thomas Efferth. (2017). Lawsone derivatives target the Wnt/β-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells. Biochemical Pharmacology. 146. 63–73. 25 indexed citations
12.
Hamdoun, Sami, Philipp Jung, & Thomas Efferth. (2017). Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia. Frontiers in Pharmacology. 8. 110–110. 40 indexed citations
13.
Hamdoun, Sami & Thomas Efferth. (2017). Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity. Oncotarget. 8(21). 35103–35115. 47 indexed citations
14.
Dirar, Amina Ibrahim, Ayman Y. Waddad, Magdi Awadalla Mohamed, et al.. (2016). IN SILICO PHARMACOKINETICS AND MOLECULAR DOCKING OF THREE LEADS ISOLATED FROM TARCONANTHUS CAMPHORATUS L. International Journal of Pharmacy and Pharmaceutical Sciences. 8(5). 71–77. 8 indexed citations
15.
Mohamed, Magdi Awadalla, Amina Ibrahim Dirar, & Sami Hamdoun. (2016). Discovery of two diacetylene glycosides as human uridine-cytidine kinase 2 inhibitors: an in silico approach. Journal of Applied Pharmaceutical Science. 34–39. 2 indexed citations
16.
Omosa, Leonidah Kerubo, Jacob O. Midiwo, Mohamed E.M. Saeed, et al.. (2015). Cytotoxicity of 91 Kenyan indigenous medicinal plants towards human CCRF-CEM leukemia cells. Journal of Ethnopharmacology. 179. 177–196. 31 indexed citations
17.
Csonka, Ákos, Sami Hamdoun, Gabriella Spengler, et al.. (2015). Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.. PubMed. 35(4). 2105–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026